RE: Warrants2 Nov 2025 23:49
DH, I think the consensus is the ones in the 11th march placing
"Hemogenyx Pharmaceuticals plc (LSE: HEMO) is pleased to announce that it was approached by an institution wishing to make an investment into the Company; this investor will subscribe £709,200 for the issue of 394,000 new Ordinary Shares (the "Subscription Shares") at £1.80 per share.
The subscribing institution will also receive a one-for-two warrant, exercisable at a price of £3.50 per share for each share subscribed (the "Warrants")."